Creative Medical Technology Holdings, Inc.

Healthcare · Biotechnology · United States

Last price 0.655 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.32M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1...